Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 12, Pages 1517-1528
Publisher
Springer Nature
Online
2015-06-29
DOI
10.1038/onc.2015.214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation
- (2015) Hamid Zia et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Proteomic Study of Microsomal Proteins Reveals a Key Role forArabidopsisAnnexin 1 in Mediating Heat Stress-Induced Increase in Intracellular Calcium Levels
- (2015) Xu Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer
- (2015) Tianpeng Zhang et al. PLoS One
- De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells
- (2015) Yi-Wen Chang et al. Oncotarget
- CYP3A4 Expression in Breast Cancer and its Association with Risk Factors in Mexican Women
- (2014) Esau Floriano-Sanchez et al. Asian Pacific Journal of Cancer Prevention
- Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
- (2014) Mathilde His et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer
- (2014) Monica N. Schointuch et al. GYNECOLOGIC ONCOLOGY
- Human Liver Cytochrome P450 3A4 Ubiquitination
- (2014) YongQiang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The ubiquitin–proteasome-system
- (2013) Thomas Sommer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
- (2013) Florian Bassermann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
- (2013) Mo Li et al. CANCER CELL
- Siah: A Promising Anticancer Target
- (2013) C. S. F. Wong et al. CANCER RESEARCH
- Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation
- (2013) Julien Bertrand et al. PROTEOMICS
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- A Critical Role for GRP78/BiP in the Tumor Microenvironment for Neovascularization during Tumor Growth and Metastasis
- (2011) D. Dong et al. CANCER RESEARCH
- Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer
- (2011) Tetsuya Fujimura et al. CANCER SCIENCE
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs)
- (2011) Fernando Lopitz-Otsoa et al. Journal of Proteomics
- CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer
- (2011) Kenichi Sakurai et al. SURGERY TODAY
- Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
- (2010) Yu-Jia Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Downregulation of MicroRNA miR-520h by E1A Contributes to Anticancer Activity
- (2010) Jen-Liang Su et al. CANCER RESEARCH
- Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase
- (2010) Youngah Jo et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- A Role for KAI1 in Promotion of Cell Proliferation and Mammary Gland Hyperplasia by the gp78 Ubiquitin Ligase
- (2010) Bharat Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells
- (2010) Rekha Rao et al. MOLECULAR CANCER THERAPEUTICS
- Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
- (2010) Lynn Bedford et al. NATURE REVIEWS DRUG DISCOVERY
- RING Domain E3 Ubiquitin Ligases
- (2009) Raymond J. Deshaies et al. Annual Review of Biochemistry
- Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation
- (2009) Zheng Ying et al. HUMAN MOLECULAR GENETICS
- Identification of Residues on Hsp70 and Hsp90 Ubiquitinated by the Cochaperone CHIP
- (2009) Lenka Kundrat et al. JOURNAL OF MOLECULAR BIOLOGY
- The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase
- (2009) Maria Fairbank et al. Molecular BioSystems
- HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
- (2008) R. Rao et al. BLOOD
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90 in Tumor Cell Invasion
- (2008) Y. Yang et al. CANCER RESEARCH
- Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development
- (2008) D. Dong et al. CANCER RESEARCH
- Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention
- (2008) C.-C. Chiu et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started